Physician profile
David Jonathan Framm
NPI 1023031598
$697.33
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $55.93 · 2022: $95.82 · 2023: $260 · 2024: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $401.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $400.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $194.60 | 2019-2024 | Camzyos, Eliquis |
| Amgen INC. | $87.19 | 2020-2024 | Repatha |
| Janssen Pharmaceuticals, INC | $81.87 | 2019-2023 | Xarelto |
| Philips North America LLC | $77.15 | 2023-2024 | (Ck4) Mcot |
| Sanofi-Aventis U.S. LLC | $56.73 | 2020-2024 | |
| Atricure, INC. | $43.53 | 2022 | |
| Vital Connect, INC | $39.72 | 2023 | Vitalpatch Rtm |
| Pfizer INC. | $23.84 | 2019 | |
| Celgene Corporation | $16.15 | 2023 | Zeposia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.61 | 2019 | |
| Medicomp INC | $15.58 | 2023 | Telepatch Cardiac Monitor |
| Irhythm Technologies, INC. | $15.36 | 2023 | Zio Xt Patch |
| Janssen Biotech, INC. | $15.30 | 2019 | |
| Boston Scientific Corporation | $14.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Framm listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.